Metraipolis › archive › dc_0cc59abe334f

Endocrine-disrupting chemicals in metabolic bone diseases, including osteoporosis — Europe PMC PMID:41488244

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41488244
DOI
10.55730/1300-0144.6128
License (as archived)
solo-consultazione
Archived
2026-11-07T09:44:33.736Z
SHA-256 of the archived text
9f77511931d358eb11979c69511b043ff93e5dd19e946ac458664048a54b003c
Stable URL of this page
https://metraipolis.com/documento/dc_0cc59abe334f

How to cite

Endocrine-disrupting chemicals in metabolic bone diseases, including osteoporosis — Europe PMC PMID:41488244 — Europe PMC (en), https://europepmc.org/article/MED/41488244 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0cc59abe334f (Metraipolis archive dc_0cc59abe334f, sha256 9f77511931d358eb11979c69511b043ff93e5dd19e946ac458664048a54b003c)
BibTeX
@misc{dc0cc59abe334f,
  title = {Endocrine-disrupting chemicals in metabolic bone diseases, including osteoporosis — Europe PMC PMID:41488244},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41488244},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0cc59abe334f; sha256 9f77511931d358eb11979c69511b043ff93e5dd19e946ac458664048a54b003c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41488244. Agents can read the archived copy with the MCP tool read_document.